Immunogenicity of recombinant human erythropoietin in Korea: A two-year cross-sectional study-Reference-Cited by-同舟云学术

Immunogenicity of recombinant human erythropoietin in Korea: A two-year cross-sectional study

Published:2012-07 Issue:4 Volume:40 Page:254-261
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Shin Sug-Kyun,Moon Sung Jin,Ha Sung Kyu,Jo Young-Il,Lee Tae-Won,Lee Young Sook,Kim Yang-Wook,Kim Dae Joong,Kim Jin Kuk,Yoo Tae-Hyun,Lee Kyu-Beck,Choi Seung Ok,Kang Ea Wha,Lee Kang Wook,Kim Sung-Jo,Kim Sang Kyum,Heo Tae-Hwe

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference22 articles.

1. In the erythropoietin era, can we forget alternative or adjunctive therapies for renal anaemia management? The androgen example;Navarro;Nephrol Dial Transplant,2003

2. Epoetin-associated pure red cell aplasia: past, present, and future considerations;McKoy;Transfusion,2008

3. Pure red-cell aplasia and epoetin therapy;Bennett;N Engl J Med,2004

4. Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?;Locatelli;Nephrol Dial Transplant,2004

5. High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases;Schonholzer;Nephrol Dial Transplant,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticulate impurities in the pharmaceutical excipient trehalose induce an early immune response;European Journal of Pharmaceutics and Biopharmaceutics;2023-08

2. Case report: Dynamic antibody monitoring in a case of anti-recombinant human erythropoietin-mediated pure red cell aplasia with prolonged course after kidney transplantation;Frontiers in Immunology;2022-11-29

3. Antibodies to Erythropoietin Are Associated with Erythropoietin Resistance in Hemodialysis Patients in KwaZulu-Natal (South Africa);Saudi Journal of Kidney Diseases and Transplantation;2020

4. Harmonization and standardization of immunogenicity assessment of biotherapeutic products;Bioanalysis;2019-09

5. TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity;The AAPS Journal;2019-08-02